Literature DB >> 28231462

The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.

Elma Aflaki1, Wendy Westbroek1, Ellen Sidransky2.   

Abstract

The discovery of a link between mutations in GBA1, encoding the lysosomal enzyme glucocerebrosidase, and the synucleinopathies directly resulted from the clinical recognition of patients with Gaucher disease with parkinsonism. Mutations in GBA1 are now the most common known genetic risk factor for several Lewy body disorders, and an inverse relationship exists between levels of glucocerebrosidase and oligomeric α-synuclein. While the underlying mechanisms are still debated, this complicated association is shedding light on the role of lysosomes in neurodegenerative disorders, demonstrating how insights from a rare disorder can direct research into the pathogenesis and therapy of seemingly unrelated common diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Gaucher disease; alpha-synuclein; autophagy; glucocerebrosidase; lysosome; parkinsonism

Mesh:

Substances:

Year:  2017        PMID: 28231462      PMCID: PMC5327952          DOI: 10.1016/j.neuron.2017.01.018

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  97 in total

1.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Debby Tsuang; Haley Huston; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

2.  iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.

Authors:  Chris M Woodard; Brian A Campos; Sheng-Han Kuo; Melissa J Nirenberg; Michael W Nestor; Matthew Zimmer; Eugene V Mosharov; David Sulzer; Hongyan Zhou; Daniel Paull; Lorraine Clark; Eric E Schadt; Sergio Pablo Sardi; Lee Rubin; Kevin Eggan; Mathew Brock; Scott Lipnick; Mahendra Rao; Stephen Chang; Aiqun Li; Scott A Noggle
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

Review 3.  Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.

Authors:  S Pablo Sardi; Seng H Cheng; Lamya S Shihabuddin
Journal:  Prog Neurobiol       Date:  2015-01-06       Impact factor: 11.685

4.  The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice.

Authors:  Zhuo Luan; Linjing Li; Katsumi Higaki; Eiji Nanba; Yoshiyuki Suzuki; Kousaku Ohno
Journal:  Brain Dev       Date:  2012-06-07       Impact factor: 1.961

5.  Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.

Authors:  Helen Michelakakis; Georgia Xiromerisiou; Efthimios Dardiotis; Maria Bozi; Demetrios Vassilatis; Persa-Maria Kountra; Gianna Patramani; Marina Moraitou; Dimitra Papadimitriou; Eleftherios Stamboulis; Leonidas Stefanis; Elias Zintzaras; Georgios M Hadjigeorgiou
Journal:  Mov Disord       Date:  2012-01-05       Impact factor: 10.338

6.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

7.  TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.

Authors:  Mickael Decressac; Bengt Mattsson; Pia Weikop; Martin Lundblad; Johan Jakobsson; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

8.  A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment.

Authors:  Paul A Gramlich; Wendy Westbroek; Ricardo A Feldman; Ola Awad; Nicholas Mello; Mary P Remington; Ying Sun; Wujuan Zhang; Ellen Sidransky; Michael J Betenbaugh; Paul S Fishman
Journal:  J Biotechnol       Date:  2016-01-18       Impact factor: 3.307

9.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

Authors:  Marie Y Davis; Catherine O Johnson; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; David Eidelberg; Paul J Mattis; Martin Niethammer; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Megan Smith; Ignacio F Mata; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

10.  Unfolded protein response in Gaucher disease: from human to Drosophila.

Authors:  Gali Maor; Sigal Rencus-Lazar; Mirella Filocamo; Hermann Steller; Daniel Segal; Mia Horowitz
Journal:  Orphanet J Rare Dis       Date:  2013-09-11       Impact factor: 4.123

View more
  59 in total

Review 1.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

Review 2.  The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.

Authors:  Lena F Burbulla; Dimitri Krainc
Journal:  Neurobiol Dis       Date:  2019-07-25       Impact factor: 5.996

Review 3.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 4.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

Review 5.  Emptying the stores: lysosomal diseases and therapeutic strategies.

Authors:  Frances M Platt
Journal:  Nat Rev Drug Discov       Date:  2017-11-17       Impact factor: 84.694

Review 6.  Glucocerebrosidase as a therapeutic target for Parkinson's disease.

Authors:  Yu Chen; Richard Sam; Pankaj Sharma; Lu Chen; Jenny Do; Ellen Sidransky
Journal:  Expert Opin Ther Targets       Date:  2020-02-27       Impact factor: 6.902

7.  Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.

Authors:  Nahid Tayebi; Loukia Parisiadou; Bahafta Berhe; Ashley N Gonzalez; Jenny Serra-Vinardell; Raphael J Tamargo; Emerson Maniwang; Zachary Sorrentino; Hideji Fujiwara; Richard J Grey; Shahzeb Hassan; Yotam N Blech-Hermoni; Chuyu Chen; Ryan McGlinchey; Chrissy Makariou-Pikis; Mieu Brooks; Edward I Ginns; Daniel S Ory; Benoit I Giasson; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2017-11-21       Impact factor: 4.797

8.  Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.

Authors:  Myung Jong Kim; Sohee Jeon; Lena F Burbulla; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 9.  Lysosomal storage diseases.

Authors:  Frances M Platt; Alessandra d'Azzo; Beverly L Davidson; Elizabeth F Neufeld; Cynthia J Tifft
Journal:  Nat Rev Dis Primers       Date:  2018-10-01       Impact factor: 52.329

10.  Measurement of GCase Activity in Cultured Cells.

Authors:  Yuri Shojima; Jun Ogata; Taiji Tsunemi; Yuzuru Imai; Nobutaka Hattori
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.